Structure-based design and synthesis of N-[2-(1-piperidinylethyl)-N′-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)-N′-[2-(5-bromopyridyl)]-thiourea as potent inhibitors of HIV-1 reverse transcriptase

被引：0

作者：

Vig, R ^{[1
]}

Mao, C ^{[1
]}

Venkatachalam, TK ^{[1
]}

Sudbeck, EA ^{[1
]}

Uckun, FM ^{[1
]}

机构：

[1] Wayne Hughes Inst, Drug Discovery Program, St Paul, MN 55113 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1998年 / 216卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

232-MEDI

引用

页码：U271 / U271

页数：1

共 50 条

[1] Structure-based design of N-[2-(1-piperidinylethyl)]-N′-[2-(5-bromopyridyl]-thiourea and N-[2-(1-piperazinylethyl)]-N′-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase
Mao, C
Vig, R
Venkatachalam, TK
Sudbeck, EA
Uckun, FM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (16) : 2213 - 2218
[2] N-[2-(1-cyclohexenyl)ethyl]-N′-[2-(5-bromopyridyl)]-thiourea and N′-[2-(1-cyclohexenyl)ethyl]-N′-[2-(5-chloropyridyl)]- thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1
Uckun, FM
Mao, C
Pendergrass, S
Maher, D
Zhu, D
Tuel-Ahlgren, L
Venkatachalam, TK
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (18) : 2721 - 2726
[3] Evaluation of the Pharmacokinetic Features and Tissue Distribution of the Potent Nonnucleoside Inhibitor of HIV-1 Reverse Transcriptase, N-[2-(2-fluorophenethyl)]-N′-[2-(5-bromopyridyl)]-thiourea (HI-240) with an Analytical HPLC Method
Chun-Lin Chen
Fatih M. Uckun
Pharmaceutical Research, 1999, 16 : 1226 - 1232
[4] Evaluation of the pharmacokinetic features and tissue distribution of the potent nonnucleoside inhibitor of HIV-1 reverse transcriptase, N-[2-(2-fluorophenethyl)]-N′-[2-(5-bromopyridyl)]-thiourea (HI-240) with an analytical HPLC method
Chen, CL
Uckun, FM
PHARMACEUTICAL RESEARCH, 1999, 16 (08) : 1226 - 1232
[5] In vivo toxicity, pharmacokinetic features and tissue distribution of N-[2-(2,5-dimethoxyphenylethyl)]-N′-[2-(5-bromopyridyl)]-thiourea (HI-236), a potent non-nucleoside inhibitor of HIV-1 reverse transcriptase
Chen, CL
Venkatachalam, TK
Waurzyniak, B
Chelstrom, L
Uckun, FM
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2001, 51 (07): : 574 - 581
[6] N-[2-(4-methylphenyl)ethyl]-N′-[2-(5-bromopyridyl)]-thiourea as a potent inhibitor of NNRTI-resistant and multidrug-resistant human immunodeficiency virus type 1
Uckun, FM
Mao, C
Pendergrass, S
Maher, D
Zhu, D
Tuel-Ahlgren, L
Venkatachalam, TK
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 2000, 11 (02): : 135 - 140
[7] N′-[2-(2-thiophene)ethyl]-N′-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1
Uckun, FM
Pendergrass, S
Maher, D
Zhu, D
Tuel-Ahlgren, L
Mao, C
Venkatachalam, TK
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (24) : 3411 - 3416
[8] N′-[2-(2-thiophene)ethyl]-N′-[2-(5-bromopyridyl)] thiourea (HI-443), a rationally designed non-nucleoside reverse transcriptase inhibitor compound with potent Anti-HIV activity
Uckun, Fatih M.
Qazi, Sanjive
Venkatachalam, Taracad
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2007, 57 (05): : 278 - 285
[9] Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N′-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus
Mao, C
Sudbeck, EA
Venkatachalam, TK
Uckun, FM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (11) : 1593 - 1598
[10] In vivo pharmacokinetics, metabolism, toxicity, and anti-HIV activity of N′-[2-(2-thiophene)ethyl]-N′-[2-(5-bromopyridyl)]thiourea (HI-443), a potent non-nucleoside inhibitor of HIV reverse transcriptase
Uckun, Fatih M.
Tibbles, Heather E.
Venkatachalam, Taracad K.
Erbeck, Douglas
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2007, 57 (07): : 483 - 496

← 1 2 3 4 5 →